This topic contains a solution. Click here to go to the answer

Author Question: A patient comes to the clinic with allergic rhinitis. Which of the following second-generation ... (Read 88 times)

D2AR0N

  • Hero Member
  • *****
  • Posts: 561
A patient comes to the clinic with allergic rhinitis. Which of the following second-generation agents, administered nasally, would be most appropriate for this patient?
 
  a. Azelastine (Astelin)
  b. Chlorpheniramine (Chlor-Trimeton)
  c. Desloratadine (Clarinex)
  d. Phenindamine (Nolahist)

Question 2

Two nursing students are discussing the indications for use of an H1 blocker. One student quizzes the other by asking, Which of the following patients would least likely benefit from the use of an H1 blocker?
 
  The other student would be correct to respond that the patient who would least likely benefit from an H1 blocker would be a patient with
  a. a common cold.
  b. motion sickness.
  c. pruritus.
  d. rhinitis.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ryansturges

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

ANS: A
Azelastine blocks the release of histamine and is indicated for allergic or vasomotor rhinitis. It is administered by nasal spray and is a second-generation medication.
Chlorpheniramine is a first-generation agent and is administered by mouth.
Desloratadine is a second-generation medication administered only by mouth.
Phenindamine is also a first-generation medication taken by mouth.

Answer to Question 2

ANS: A
Antihistamines are of practically no value against the common cold. They neither prevent colds nor shorten their duration.
Antihistamines are useful for treating allergic disorders, motion sickness, itching, and insomnia.
Antihistamines show a moderate reduction in rhinorrhea.




D2AR0N

  • Member
  • Posts: 561
Reply 2 on: Jul 23, 2018
:D TYSM


shailee

  • Member
  • Posts: 392
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library